Sedana Medical AB (publ) (STO:SEDANA)
8.67
+0.05 (0.58%)
Jul 24, 2026, 5:29 PM CET
Sedana Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 51.79 | 90.98 | 193.96 | 231.18 | 607.74 | 836.18 |
Short-Term Investments | - | - | - | 150.62 | - | - |
Cash & Short-Term Investments | 51.79 | 90.98 | 193.96 | 381.8 | 607.74 | 836.18 |
Cash Growth | -60.37% | -53.09% | -49.20% | -37.18% | -27.32% | 122.29% |
Accounts Receivable | 26.7 | 29.21 | 26.54 | 24.18 | 15.85 | 20.35 |
Other Receivables | 4.33 | 11.68 | 6.29 | 5.96 | 5.21 | 6.01 |
Total Trade Receivables | 31.03 | 40.89 | 32.83 | 30.14 | 21.06 | 26.35 |
Inventory | 42.91 | 37.87 | 45.56 | 42.98 | 38.6 | 11.09 |
Other Current Assets | 4.97 | 4.01 | 5.86 | 4.7 | 6.02 | 7.12 |
Total Current Assets | 130.71 | 173.75 | 278.2 | 459.62 | 673.42 | 880.74 |
Net Property, Plant & Equipment | 12.16 | 9.76 | 10.63 | 8.33 | 14.72 | 16.79 |
Other Intangible Assets | 767.52 | 744.93 | 703.93 | 546.03 | 393.38 | 269.99 |
Goodwill | 26.51 | 25.28 | 26.57 | - | - | - |
Other Long-Term Assets | 0.62 | 0.74 | 0.07 | 0.08 | 0.08 | 0.07 |
Total Assets | 937.51 | 954.46 | 1,019 | 1,014 | 1,082 | 1,168 |
Accounts Payable | 3.62 | 5.27 | 5.95 | 5.17 | 11.27 | 15.04 |
Accrued Expenses | 22.01 | 24.52 | 28.62 | 24.83 | 22.93 | 19.74 |
Current Portion of Leases | 4.46 | 2.81 | 3.33 | 3.29 | 5.17 | 4.23 |
Other Current Liabilities | 15.08 | 18.42 | 13.75 | 9.75 | 9.49 | 22.47 |
Total Current Liabilities | 45.16 | 51.03 | 51.65 | 43.04 | 48.86 | 61.48 |
Long-Term Leases | 2.86 | 1.89 | 2.58 | 1.01 | 3.58 | 4.64 |
Other Long-Term Liabilities | 1.04 | 0.77 | 6.94 | 0.01 | 0 | - |
Total Long-Term Liabilities | 3.9 | 2.65 | 9.36 | 1.01 | 3.58 | 4.64 |
Total Liabilities | 49.06 | 53.68 | 61.17 | 44.06 | 52.43 | 66.12 |
Common Stock | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 |
Additional Paid-in Capital | 1,230 | 1,229 | 1,227 | 1,226 | 1,226 | 1,222 |
Accumulated Other Comprehensive Income | -3.81 | -3.73 | -3.79 | -2.2 | -2.65 | 0.18 |
Retained Earnings | -339.96 | -326.64 | -267.4 | -256.72 | -197.11 | -123.61 |
Shareholders' Equity | 888.45 | 900.78 | 958.23 | 970 | 1,029 | 1,101 |
Total Liabilities & Equity | 937.51 | 954.46 | 1,019 | 1,014 | 1,082 | 1,168 |
Total Debt | 7.32 | 4.7 | 5.92 | 4.31 | 8.74 | 8.87 |
Net Cash (Debt) | 44.47 | 86.28 | 188.04 | 377.5 | 599 | 827.31 |
Net Cash Growth | -64.66% | -54.12% | -50.19% | -36.98% | -27.60% | 124.89% |
Net Cash Per Share | 0.45 | 0.87 | 1.89 | 3.80 | 6.03 | 8.90 |
Book Value | 888.45 | 900.78 | 958.23 | 970 | 1,029 | 1,101 |
Book Value Per Share | 8.94 | 9.07 | 9.65 | 9.76 | 10.36 | 11.85 |
Tangible Book Value | 94.42 | 130.57 | 227.73 | 423.96 | 635.78 | 831.47 |
Tangible Book Value Per Share | 0.95 | 1.31 | 2.29 | 4.27 | 6.40 | 8.94 |